市场调查报告书
商品编码
1403422
到 2030 年超音波设备的市场预测:按产品、应用、最终用户和地区进行的全球分析Ultrasound Equipment Market Forecasts to 2030 - Global Analysis By Product (Compact, Table Top and Other Products), Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球超音波设备市场规模将达到 95 亿美元,预计到 2030 年将达到 177 亿美元,预测期内复合年增长率为 9.3%。
使用高频声波在体内产生影像的设备称为超音波设备。器官、组织和身体结构(包括肌肉、肌腱、关节以及心臟、肝臟和肾臟等内臟器官)的可视化是典型的医学诊断技术。当超音波诊断设备发出的声波在结构内反射时,它们会产生影像,医疗专业人员可以使用这些影像来诊断和追踪疾病的进展。
根据英国NHS 2021年12月公布的资料,2020年8月至2021年8月期间,英国约有944万名NHS患者接受了超音波诊断。
超音波影像成像系统的技术进步
技术创新是驱动市场的关键因素。超音波技术的持续创新和进步正在改变整个产业。弹性成像、增强移动性、3D/4D 成像和 AI 整合等尖端功能正在改变诊断能力并显着改善患者照护。这些技术进步提高了诊断测试的速度和准确性,并改善了治疗计划。
有限报销政策
医疗报销不足可能会阻碍超音波技术的进步。报销减少可能会限制分配给医疗保健专业人员超音波设备培训的资金。医疗费用的下降可能会阻碍医疗机构投资最新的超音波设备。为了省钱,他们可能会选择使用过时或不成熟的技术,这将影响诊断的准确性和精确度。这是阻碍市场扩张的方面。
越来越重视即时诊断 (POC)
由于护理点超音波诊断的使用不断增加,该市场正在显着增长。它解释了医疗保健专业人员如何在患者床边使用超音波来快速诊断和治疗患者。这些设备体积小、重量轻,通常由电池供电,可以在困难的情况下进行现场护理。透过普及贫困地区,我们可以改善整体医疗保健可近性并解决未满足的医疗保健需求。超音波检测服务现在变得越来越广泛。
维护和升级成本高
超音波设备的初始购买成本较高,这对于小型医院或人口稀少地区的医院来说可能是一个主要障碍。由于需要设备升级和持续维护以跟上技术进步,医疗保健组织可能面临财务挑战。此外,在资源有限且预算紧张的医疗保健环境中,超音波设备的高成本可能会阻碍其广泛普及。
COVID-19 的爆发对超音波市场产生了整体负面影响。疫情扰乱了全球医疗设备供应链。市场上一些最大的公司正面临供应链中断,特别是来自新兴国家分销商的供应链中断,这些公司受到的影响尤其严重。另一方面,由于原料和零件无法在地采购,一些製造商的製造能力受到影响。
放射学产业预计将成为预测期内最大的产业
由于放射学领域人工智慧应用的增加,预计放射学领域在预测期内将出现最大的成长。 Caption AI 技术加快并简化了超音波检查,让更多医疗保健专业人员能够进行基本的心臟超音波图。该设备可以识别任何地方(包括医院、家庭和其他院外环境)高风险族群的疾病症状,包括心臟衰竭。这减少了住院时间并改善了患者的治疗效果。
预计医院领域在预测期内的复合年增长率最高。
在预测期内,由于超音波设备在医院环境中的广泛使用,医院部门预计将出现最高的复合年增长率。随着便携式系统的引入,预计 OPD 和住院部对超音波设备的需求将会增加。此外,尖端影像处理系统的使用增加以及医院和行业併购的增加活性化推动未来几年对新设备的需求。
预计北美在预测期内将占据最大的市场占有率。该地区众多竞争的存在和癌症患者数量的增加是促进该地区市场成长的主要因素。医疗保健支出的增加、对各种诊断方法的更好理解以及有利的报销政策预计将推动该地区的市场成长。
由于对更好的诊断影像设备的需求不断增加,预计亚太地区在预测期内将保持最高的复合年增长率。此外,主要企业正在采取各种策略来加强其在该地区的影响力。较低的研究成本、宽鬆的监管指南以及各国政府增加的研发资金等因素使该地区成为具有吸引力的研发地区。
According to Stratistics MRC, the Global Ultrasound Equipment Market is accounted for $9.5 billion in 2023 and is expected to reach $17.7 billion by 2030 growing at a CAGR of 9.3% during the forecast period. Devices that create pictures of the inside of the body using high-frequency sound waves are referred to as ultrasound equipment. Visualizing organs, tissues, and bodily structures, including muscles, tendons, joints, and internal organs like the heart, liver, and kidneys, is a typical medical diagnostic technique. When sound waves are emitted by ultrasound devices and bounce off inside structures, pictures are produced that medical practitioners can use to diagnose ailments or track the course of diseases.
According to a data published by NHS England in December 2021, around 9.44 million NHS patients in the U.K., underwent diagnostic ultrasonography from August 2020 to August 2021.
Innovations in technology are key factors driving the market. Due to ongoing innovation and advancements in ultrasonography technology, the industry is undergoing a major change. Cutting-edge features including elastography, improved mobility, 3D/4D imaging, and AI integration are transforming diagnostic capabilities and greatly enhancing patient care. These technological advancements improve treatment planning in addition to improving diagnostic tests speed and accuracy.
Insufficient reimbursement might hinder the advancement of ultrasound technologies. Decreased reimbursement rates may restrict the amount of funds allotted for ultrasound equipment training for medical personnel. Lower reimbursement might deter medical institutions from investing in the newest ultrasound equipment. To save money, they can choose to use outdated or less sophisticated technology, which would affect the precision and caliber of diagnosis. This is the aspect preventing the market from expanding.
The market is seeing significant growth due to the growing use of point-of-care ultrasonography. It describes how medical professionals utilize ultrasound at the patient's bedside to quickly diagnose and treat patients. These devices allow point-of-care usage even in difficult circumstances since they are small, light, and frequently battery-operated. By reaching underprivileged communities, this increases the accessibility of healthcare overall and addresses unmet healthcare needs. Ultrasound services are now more widely available.
Ultrasound equipment can be expensive to buy initially, which can be a major barrier for smaller hospitals or those in underdeveloped areas. Healthcare institutions may face financial difficulties due to the requirement for equipment upgrades to stay up with technological breakthroughs and ongoing upkeep. Furthermore, in healthcare settings with limited resources and tight budgets, the high cost of ultrasound instruments may prevent them from being widely available.
The outbreak of COVID-19 has had an overall negative effect on the ultrasound market. The pandemic has generated disruptions in the supply chain of medical devices globally. Some of the major players operating in the market have faced supply chain disruptions especially from distributors in severely impacted emerging countries. On the other hand, the manufacturing capacity of a few players has been affected due to the unavailability of locally sourced raw materials or parts.
The radiology segment is expected to be the largest during the forecast period owing to increasing application of artificial intelligence in radiology. Caption AI technologies can expedite and simplify ultrasonic examinations, enabling more medical personnel to do basic echocardiography exams. This gadget can recognize symptoms of illnesses, including heart failure, in individuals who are at risk anywhere-in hospitals, homes, and other out-of-hospital settings. This reduces hospital stays and improves patient outcomes.
The hospitals segment is expected to have the highest CAGR during the forecast period owing to the extensive use of ultrasound devices in hospital settings. The need for ultrasound equipment in OPD and in-patient departments is anticipated to increase with the introduction of portable systems. In addition, a growth in the use of cutting-edge imaging systems and a rise in hospital and industry merger and acquisition activity are probably going to drive up demand for new installations in the upcoming years.
North America is projected to hold the largest market share during the forecast period. The presence of a significant number of competitors in the region and an increasing number of cancer cases are key factors contributing to regional market growth. Increasing expenditure on healthcare, a greater understanding of various methods of diagnosis, and favorable policies for reimbursement are projected to drive regional market growth.
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to the increased demand for better imaging devices. Furthermore, key players are adopting different strategies to strengthen their presence in this region. Factors, such as low research costs, less stringent regulatory guidelines, increased government funding for the R&D sector's development in the respective countries, are making the region attractive for research studies.
Some of the key players in Ultrasound Equipment market include Philips Healthcare, Canon Medical Systems Corp, Hitachi Healthcare Manufacturing Ltd, Samsung Medison Co Ltd, GE Healthcare, Siemens Healthineers AG, Fujifilm Holdings Corp, Esaote SpA, Mindray, Analogic Corporation, Sonosite, Toshiba Medical Systems and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
In March 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched new handheld ultrasound device TE Air, that provides enhanced point-of-care ultrasound imaging with an array of practical benefits for radiologists.
In February 2022, Koninklijke Philips N.V., launched Lumify, its handheld point-of-care ultrasound solution for expanding its portfolio to offer advanced hemodynamic assessment and measurement capabilities.